2016 Cancer Annual Report | Page 10

INFUSION Services

Renown Infusion Services provides outpatient treatment to adults 16 years of age and older . We are open 365 days a year , with 25 patient treatment areas including 3 private rooms and 21 interactive treatment bays with Wi-Fi access and a personal television . Our on-site pharmacy and laboratory is staffed with pharmacists and a lab technician , who work alongside the oncology certified nurses enabling us to provide comprehensive care to you .
In winter 2016 , construction will begin in the Institute for Cancer to expand our Infusion Services , adding four additional treatment bays to meet the needs of our growing community .
We treat a variety of diagnoses including , but not limited to , cancer , multiple sclerosis , anemia , osteoporosis , osteomyelitis , rheumatoid arthritis and genetic disorders . We offer precision treatments such as clinical trials , and the latest immunotherapy and chemotherapy drugs . Our nurses work in collaboration with your healthcare team to ensure quality care . They perform therapeutic phlebotomies , administer IV medications , give injections and administer blood and platelet transfusions . The nurses also perform lab draws , central line care and provide education about specific treatments .

INPATIENT Care

Brandi Griggs , RN , BSN , OCN Manager , Infusion Services
Inpatient Cancer Care has 27 private rooms specializing in the care of all types of cancer . All of our nursing staff earn competency to administer chemotherapy and biotherapy via national certificate ( Oncology Nursing Society / Oncology Nursing Certification Corporation ) or internally via Renown ’ s Chemotherapy and Biotherapy Certificate Course . Instruction in these courses is rigorous , and provides training in the administration of Chemotherapy and Biotherapy agents along with symptom management , safe handling , and psychosocial dimensions of care .
One of the most serious side effects from chemotherapy is known as Febrile Neutropenia , a condition of having an unusually low number of cells called neutropils and a fever of 100.4 degrees Fahrenheit or greater . Renown developed a febrile Neutropenia Protocol in 2016 which allows clinicians to identify cancer patients at risk for this life threatening side effect quickly . Once identified , these patients are immediately moved into a prescribed antibiotic therapy protocol . By following this protocol , we have improved positive response outcomes and our patient ’ s experience . Our high risk patients with Neutropenia are provided alert cards . Patients can present these cards to any ER employee and receive the expedited care of the Neutropenia protocol .
9